Hoping Chinese Itrack Advance approval soon.
With more impressive data coming through in the treatment of closed angle glaucoma EYE could see some rapid uptake in China.
Another potential catalyst to look forward to.
Nova Eye Medical (EYE) Discussion, page-2800
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.010(4.44%) |
Mkt cap ! $53.77M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 23.5¢ | 22.0¢ | $170K | 755.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 42905 | 22.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 9999 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2024 (20 minute delay) ? |
|
|||||
|
Last
22.5¢ |
Change
0.010 ( 2.27 %) |
||||
| Open | High | Low | Volume | ||
| 22.5¢ | 23.0¢ | 22.0¢ | 419541 | ||
| Last updated 15.49pm 17/06/2024 ? | |||||
| EYE (ASX) Chart |
